Abstract

Neuropilin-1 (Nrp1) plays important roles in axonal guidance in neurons and in the growth of new blood vessels. There is also a growing appreciation for roles played by neuropilin-1 in the immune response. This molecule is important for the function of regulatory T cells; however, roles in other T cell populations have not been identified. Here, we show that neuropilin-1 is expressed during the peak of the antiviral CD8 T cell response during murine gammaherpesvirus infection. Using a conditional knockout model, we deleted Nrp1 either before infection or after CD8 T cell memory had been established. We found that deletion of Nrp1 skewed the acute CD8 T cell response toward a memory precursor-like phenotype; however, the ensuing resting memory response was similar regardless of Nrp1 expression. Interestingly, Nrp1 deletion had differing effects on the recall response depending on the timing of deletion. When deleted before infection, Nrp1 deficiency inhibited the secondary response. Deletion just prior to reexposure to virus led to an enhanced secondary response. Interestingly, these effects were observed only in mice infected with a persistent strain of murine gammaherpesvirus and not with a nonpersistent mutant strain. These data highlight a multifaceted role for neuropilin-1 in memory CD8 T cell differentiation, dependent upon the stage of the T cell response and characteristics of the infectious agent. Several therapeutic anticancer therapies focus on inhibition of Nrp1 to restrict tumor growth, and so knowledge of how Nrp1 blockade may affect the CD8 T cell response will provide a better understanding of treatment consequences.IMPORTANCE CD8 T cell responses are critical to control both virus infections and tumors. The ability of these cells to persist for long periods of time can result in lifelong immunity, as relatively small populations of cells can expand rapidly to counter reexposure to the same insult. Understanding the molecules necessary for this rapid secondary expansion is critical if we are to develop therapies that can provide lifelong protection. This report shows an important and complex role for the molecule neuropilin-1 in the secondary response. Several cancer therapies targeting neuropilin-1 are in development, and this work will lead to better understanding of the effect these therapies could have upon the protective CD8 T cell response.

Highlights

  • Neuropilin-1 (Nrp1) plays important roles in axonal guidance in neurons and in the growth of new blood vessels

  • Our previous research has shown that the CD8 T cell response differs between infection with a mutant MHV-68 with a deletion in ORF73 (FS73) [15, 16], which is essential for latent infection, and infection with a revertant virus that retains the ability to persist in the host

  • Studies from our own laboratory confirmed the absence of latency by real-time PCR, in addition to the absence of latency-associated splenomegaly and mononucleosis, and showed robust primary CD8 T cell responses induced by both frameshift mutation in ORF73 (FS73) and revertant viruses

Read more

Summary

Introduction

Neuropilin-1 (Nrp1) plays important roles in axonal guidance in neurons and in the growth of new blood vessels. Deletion just prior to reexposure to virus led to an enhanced secondary response These effects were observed only in mice infected with a persistent strain of murine gammaherpesvirus and not with a nonpersistent mutant strain. A recent report showed Nrp expression on group 3 innate lymphoid cells (ILC3s) in the lung with lymphoid tissue inducer activity and suggested functions in the early development of tertiary lymphoid aggregates in the lung and/or pulmonary angiogenesis [12] These studies imply Nrp has a major impact in modulating responses to tumors and plays a role in immune regulation and tissue remodeling in other physiological settings. By means of this strain, we were able to restrict the deletion to CD8 T cells and regulate the timing of the deletion by tamoxifen administration

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.